Xellsmart Bio-pharmaceutical (suzhou) Co., Ltd.

This early-stage study tests whether a new stem cell therapy (XS228CN) is safe for people with ALS, a disease that damages nerve cells controlling movement. Researchers will give the cells to 12 adults aged 18-75 and watch for side effects over 28 days. The goal is to see if the …

This early-stage study tests whether a single injection of lab-grown nerve cells (made from stem cells) is safe for people with a recent spinal cord injury. The cells are designed to replace damaged nerve connections. The trial involves 12 adults with injuries between the neck an…

This study tests a new treatment called XS411, made from stem cells, for people with early-onset Parkinson's disease. It involves a single injection into the brain to replace damaged cells. The trial has two parts: first, a small group to check safety, then a larger group to see …

This early-stage study tests whether injecting special nerve cells into the brain is safe for people with advanced Parkinson's disease. The cells are made from stem cells in a lab and are meant to replace damaged brain cells that control movement. The trial involves 12 adults age…